Skip to main content
. 2013 Oct 17;8(10):e77713. doi: 10.1371/journal.pone.0077713

Figure 8. The effects of Dox, Mdivi-1 and co-treatment on the levels of (A) phospho-Drp1 and (B) phospho-p53 with the representative flow cytometry traces of (C) phospho-Drp1 and (D) phospho-p53.

Figure 8

**p>0.01 vs. control, ***p>0.01 vs. control, ##p<0.01 vs. doxorubicin and ###p<0.01 vs. doxorubicin.